AVP and Stroke: The limitations of the study include the relatively small sample size and the single-center design, which may potentially limit the generalization of the results. Secondly, the predictive value of copeptin in hospitalized stroke patients may be hampered by the connection between copeptin release and the body's stress responses as well as the possible rise in plasma copeptin levels in the presence of medical comorbidities.